Related Experiment Videos
Efficacy of 5,6-dihydro-5-azathymidine against cutaneous herpes simplex virus in hairless mice
Antimicrobial Agents and Chemotherapy
|April 1, 1977
Abstract:
5,6-Dihydro-5-azathymidine, administered subcutaneously, was active both prophylactically and therapeutically against cutaneous herpesvirus infection of hairless mice. Activity was comparable to that obtained with adenine arabinoside.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pyrimidinones. 1. 2-Amino-5-halo-6-aryl-4(3H)-pyrimidinones. Interferon-inducing antiviral agents.
Journal of medicinal chemistry·1985
Didemnins A and B. Effectiveness against cutaneous herpes simplex virus in mice.
Antiviral research·1983
Interferon induction by 5-halo-6-phenyl pyrimidinones.
Journal of interferon research·1980
In vitro and in vivo activity of OSUAB-0284, a preclinical candidate for Staphylococcus aureus infections.
Antimicrobial agents and chemotherapy·2026
Activity of oral β-lactams, tebipenem and ceftibuten, combined with novel oral β-lactamase inhibitors against broad-spectrum β-lactamase-producing Escherichia coli.
Antimicrobial agents and chemotherapy·2026
A multivalent CPS-CRM197 conjugate vaccine protects against severe/fatal Klebsiella pneumoniae disease in a mouse infection model.
Antimicrobial agents and chemotherapy·2026
Rifampicin-resistant Staphylococcus epidermidis implant-associated infections: the therapeutic potential of ceftaroline and daptomycin combinations.
Antimicrobial agents and chemotherapy·2026
Expanding threat of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Peru: genomic and phenotypic evidence of high-risk clones dissemination.
Antimicrobial agents and chemotherapy·2026
Dual-stage inhibition of Plasmodium falciparum by a Skeletocutis-derived fungal metabolite targeting pyruvate kinase II.
Antimicrobial agents and chemotherapy·2026
Dupilumab-Responsive Grover Disease with Concomitant Eczematous Dermatitis: A Case Report and Review of 27 Cases.
Case reports in dermatology·2026
Artesunate targets STAT3 to alleviate Hodgkin's lymphoma via JAK-STAT/PD-L1 axis.
Biochemical pharmacology·2026